Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array

Arata Kamimatsuse1, Kaoru Matsuura, Shogo Moriya

  • 1Department of Surgery, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan.

Abstract

Insights

DNA methylation of the caspase-8 gene (CASP8) is linked to unfavorable neuroblastomas. Oligoarray analysis revealed CASP8 methylation patterns correlate with clinical outcomes, aiding in neuroblastoma evaluation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Caspase-8 gene (CASP8) inactivation via DNA methylation is common in unfavorable neuroblastomas.
  • Investigating the methylation status of a specific CpG island in CASP8 is crucial for understanding neuroblastoma progression.

Purpose of the Study:

  • To evaluate the methylation status of a CpG island within the caspase-8 gene (CASP8) in neuroblastomas using oligoarrays.
  • To correlate CASP8 methylation patterns with clinical outcomes and MYCN amplification in neuroblastoma patients.

Main Methods:

  • DNA from 70 neuroblastomas was analyzed for CASP8 CpG island methylation using bisulfite modification, PCR, and a custom oligoarray.
  • Methylation status was cross-validated with sequencing and subcloning in select cases.
  • Oligoarray sensitivity was compared to traditional sequencing methods.

Main Results:

  • CASP8 methylation was detected across varying CpG loci in 52 out of 70 neuroblastomas.
  • Oligoarray analysis demonstrated potentially higher sensitivity than sequencing for detecting certain methylated CpGs.
  • Reduced CASP8 expression correlated with specific methylation patterns and was linked to MYCN amplification and poorer clinical outcomes.

Conclusions:

  • Significant differences in CASP8 CpG island methylation exist between favorable and unfavorable neuroblastoma subtypes.
  • Oligoarray-based detection of CASP8 methylation shows promise as a clinical tool for neuroblastoma evaluation.

Related Concept Videos